Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q2 FY22 Earnings Presentation
41 slides from Aster Dm Healthcare's earnings presentation, Nov 11, 2021
Slide 1: Exchange cover letter
November 11, 2021 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 40005
Slide 2: Investor Presentation – For the quarter ended 30th September 2021
Investor Presentation – For the quarter ended 30th September 2021
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Aster – Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3
Slide 5: Aster DM Healthcare – Business Overview
Aster DM Healthcare – Business Overview CAPACITY BEDS HOSPITALS One of the Largest Private GCC: 1,151 GCC: 13 healthcare service providers 4,985 27 India: 3,834 India: 14 operating in Asia (GCC and India) PATIENT VISITS – FY22 H1 CLINICS Present in 7 Countries GCC: ~7.5 mn ~8.5 mn (UAE, Saudi Arabia
Slide 6: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview Note: 1. Revenue and EBITDA shown above excludes other income 2. Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated corpo
Slide 7: Geographical Footprint
Geographical Footprint Hospitals – 13 GCC Clinics – 108 Pharmacies – 225 Hospitals – 14 Clinics – 9 INDIA United Arab Emirates Kerala Medcare Hospital, Dubai Aster Medcity, Kochi Medcare Orthopaedics and Spine Hospital Aster MIMS, Kozhikode Aster Hospital Mankhool Aster MIMS, Kottakkal Medcare Women
Slide 8: Hospitals List
Hospitals List Hospitals - GCC Location Commencement/ Capacity Operational Owned Operational Acquisition Year Beds Beds /Leased Geography Capacity Beds Medcare Hospital Dubai, UAE 2007 64 55 Leased Beds Al Raffah Hospital Muscat, Oman 2009 86 72 Leased GCC 1,151 978 Al Raffah Hospital Sohar, Oman 20
Slide 9: Pipeline Projects
Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Aster Hospital Sharjah, UAE Greenfield 80 Q3 FY 2022 Construction Leased Aster Hospital Muscat, Oman Greenfield 145 Q4 FY 2022 Construction Leased Sanad Hospital Riyadh, Saudi Arab
Slide 10: The Aster DM Healthcare Edge
The Aster DM Healthcare Edge Robust & Expansive Healthcare Ecosystem • Holistic healthcare solutions for people, including primary, secondary, tertiary and quaternary care • 27 Hospitals equipped with state-of-the-art equipment • Extensive network of 117 clinics enabling patient-feeder structure • S
Slide 11: Aster DM Healthcare - Evolution
Aster DM Healthcare - Evolution Brand “Aster” was formed, private equity Robust Growth across all Growth and Diversification into Building the foundations New geographies, segments segments and geographies; Rapid investment, further expansion aligned businesses across and service offerings Expansion
Slide 12: Robust Growth Over Last 5 Years
ROBUST GROWTH OVER LAST 5 YEARS ..Coupled with capacity creation for further growth # of Units FY17 FY18 FY19 FY20 FY21 FY22 H1 Hospitals 18 19 24 25 27 27 Clinics 96 101 114 117 115 117 Pharmacies 202 207 219 238 223 225 Total 316 327 357 380 365 369 Note: 1. Out-Patient visits mentioned above does
Slide 13: Aster – Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 12
Slide 14: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY21 Operational Information 2,200+ 2,20,000+ Cardiovascular IP Discharges Surgeries ~4.7 mn 16,100+ 1,300+ Clinic OPD Visits General Bariatric Surgeries Surgeries 1,200+ Joint 1,200+ ~ 7.5 mn Replacements Spine Surgeries Pharmacy Visits 10,000+ 480+ Urology
Slide 15: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Aster, over 30 years, has created a healthcare eco-system across two geographical regions In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient journey, while pharmacies and hospitals continue the care For complex tertiary car
Slide 16: GCC Healthcare – Unique Traits
GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat and working age population Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) Due to lower % of older population, requirement of tertiary and quaterna
Slide 17: Aster - Awards & Service Excellence - GCC
Aster - Awards & Service Excellence - GCC JCI Accreditation IHF AHPI Awards Medcare Hospital Dubai, Aster DM Healthcare, Aster Medcare Hospital Dubai, Medcare Medcare Orthopaedics and Hospital - UAE, Medcare Hospital Orthopedics and Spine Hospital, Spine Hospital, Medcare Dubai, Medcare Women and Me
Slide 18: Aster - Awards & Service Excellence - India
Aster - Awards & Service Excellence - India JCI Accreditation AHPI Awards Times All India Aster Medcity, Dr. Ramesh Aster Medcity, Aster CMI, MIMS Multispecialty Hospitals Hospital , Guntur Kozhikode, DM WIMS Wayanad, Ranking Survey 2021 Aster Aadhar Hospital Aster Medcity: Ranked 5 in Top Multispec
Slide 19: Aster – Leadership Team - Accolades
Aster – Leadership Team - Accolades Dr. Azad Moopen - Chairman and Alisha Moopen - Deputy Managing Managing Director Director Recipient of the “Padma Shri” Award, the Selected as one of the Top Next 4th highest civilian award by the Generation Indian Leaders by Forbes Government of India for being r
Slide 20: Key Highlights – FY22 Q2 (1/2)
Key Highlights – FY 22 Q2 (1/2) Clinical Highlights - India • Aster CMI Hospital performs the first ever Covid lung transplant in Karnataka on a 29 year old anesthetist and critical care physician from a private hospital involved in Covid care • Aster RV Hospital performs the 1st Bilateral Lung Tran
Slide 21: Key Highlights – FY22 Q2 (2/2)
Key Highlights – FY 22 Q2 (2/2) Clinical Highlights - GCC • An Ethiopian woman who had slipped into coma after suffering from severe brain damage due to hypoxia wakes up from coma after 8 months at Aster Hospital in Al Qusais, Dubai • Doctors at Aster Hospital Qusais treated a rare case of Fitz-Hugh
Slide 22: Aster – Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 21
Slide 23: Revenue and Profitability Snapshot – FY22 Q2
Revenue and Profitability Snapshot – FY22 Q2 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue, EBITDA and PAT (Post-NCI) is ~ 12%, ~ 27% and ~ 227% respectively Notes: 1. Above financials are presented in INR Crore 2. Percentages mentioned insi
Slide 24: Revenue and Profitability Snapshot – FY22 H1
Revenue and Profitability Snapshot – FY22 H1 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue and EBITDA is ~23% and ~52% respectively Notes: 1. Above financials are presented in INR Crore 2. Percentages mentioned inside the bars are % to reven
Slide 25: Geography-wise Financial – Snapshot - Quarterly
Geography-wise Financial – Snapshot - Quarterly GCC INDIA CONSOLIDATED FY21 Q2 FY22 Q2 FY21 Q2 FY22 Q2 FY21 Q2 FY22 Q2 Revenue (₹) 1,828 Cr 1,896 Cr 415 Cr 609 Cr 2,243 Cr 2,504 Cr EBITDA (₹) 223 Cr 241 Cr 48 Cr 102 Cr 271 Cr 343 Cr PAT (Post-NCI) (₹) 47 Cr 84 Cr -14 Cr 23 Cr 33 Cr 107 Cr Notes: 1.
Slide 26: Geography-wise Financial – Snapshot – Half-Yearly
Geography-wise Financial – Snapshot – Half-Yearly GCC INDIA CONSOLIDATED FY21 H1 FY22 H1 FY21 H1 FY22 H1 FY21 H1 FY22 H1 Revenue (₹) 3,276 Cr 3,717 Cr 714 Cr 1,159 Cr 3,990 Cr 4,876 Cr EBITDA (₹) 353 Cr 450 Cr 61 Cr 173 Cr 414 Cr 624 Cr PAT (Post NCI) (₹) 3 Cr 130 Cr -53 Cr 21 Cr -50 Cr 151 Cr Notes
Slide 27: Geography-wise Business – Snapshot - Quarterly
Geography-wise Business – Snapshot - Quarterly GCC INDIA CONSOLIDATED FY21 Q2 FY22 Q2 FY21 Q2 FY22 Q2 FY21 Q2 FY22 Q2 Total Capacity Beds 1,163 1,151 3,708 3,834 4,871 4,985 Operational Beds 943 978 2,664 2,776 3,607 3,754 ALOS (Days) 2.0 1.9 4.1 3.8 3.2 3.1 Occupancy 56% 51% 58% 70% 58% 65% Outpati
Slide 28: Geography-wise Business – Snapshot – Half-Yearly
Geography-wise Business – Snapshot – Half-Yearly GCC INDIA CONSOLIDATED FY21 H1 FY22 H1 FY21 H1 FY22 H1 FY21 H1 FY22 H1 Total Capacity Beds 1,163 1,151 3,708 3,834 4,871 4,985 Operational Beds 943 978 2,664 2,776 3,607 3,754 ALOS (Days) 2.2 1.9 3.8 4.1 3.2 3.3 Occupancy 57% 50% 51% 70% 53% 65% Outpa
Slide 29: Segmental Performance FY22 Q2
Segmental Performance FY22 Q2 Growth % India - India - Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY22 Q2 GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 108
Slide 30: Segmental Performance FY22 H1
Segmental Performance FY22 H1 Growth % India - India - Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY22 H1 GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 108
Slide 31: Maturity Wise Hospital Performance – GCC FY22 H1
Maturity Wise Hospital Performance – GCC FY22 H1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Crs.) 12% 17% ₹ 36 3 49% 16.8% 0-3 Years ₹ 214 168 ₹ ~142,400 Over 3 Years 88% 83% ₹ ~196,800 51% ₹ 241 10 ₹ 1,506 810 16.0%
Slide 32: Maturity Wise Hospital Performance – India FY22 H1
Maturity Wise Hospital Performance – India FY22 H1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Crs.) 16% 15% ₹ 21 0-3 Years 3 ₹ ~32,500 73% 12.0% ₹ 177 411 Over 3 85% 70% ₹ 176 Years 10 84% ₹ ~31,800 18.8 % ₹ 934 2,365
Slide 33: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY22 Q1 FY21 Q2 FY22 Q2 Y-o-Y Gw% Q-o-Q Gw% Revenue from operations 2,372 2,243 2,504 12% 6% Material consumption 714 660 728 Doctors cost 483 473 500 Employee cost (excl. doctors) 462 413 502 Laboratory outsourcing charges 73 44
Slide 34: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY21H1 FY22H1 Gw% Revenue from operations 3,990 4,876 22% Material consumption 1,229 1,442 Doctors cost 842 982 Employee cost (excl. doctors) 787 964 Laboratory outsourcing charges 63 136 Other expenses 655 728 EBITDA (excl. othe
Slide 35: Financial Summary – Balance Sheet & Ratios
Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Sep 30, Particulars (INR Cr) 2021 2021 LIABILITIES Shareholders Equity 3,372 3,539 Minority Interest 462 487 Gross Debt 2,309 2,237 Lease Liabilities - INDAS116 2,495 2,559 Other current and non-current liabilities 3,005 3,148 As at Mar
Slide 36: Strategy and Leadership
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 35
Slide 37: GCC Strategy
GCC Strategy Strengthening of our medical tourism network • To further strengthen integration of GCC & India operations to provide consistent quality experience to patients across geographies • To position our premium segment Medcare hospitals as service provider of choice for affluent international
Slide 38: India Strategy
India Strategy Aster DM Healthcare hopes to leverage its In line with focus on Focus on large format extensive experience derisking hospitals in Tier 1 of working in a 100% business – cities – Hospitals insurance market in target of 25% in Tier 1 cities the GCC to derive of overall estimated to bett
Slide 39: Aster Leadership Team
Aster Leadership Team Dr. Azad Moopen Chairman and Managing Director T. J. Wilson Alisha Moopen Dr. Shanila Laiju Group Head – Governance and Deputy Managing Director Chief Executive Officer, Medcare Corporate Affairs, GCC Hospitals & Medical Centres Sreenath Reddy Dr. Sherbaz Bichu Brandon Rowberry
Slide 40: Aster Board of Directors
Aster Board of Directors Daniel Robert Dr. Layla Mohamed Hassan Dr. Azad Moopen Mintz Ali Al-Marzooqi Chairman and Managing Director Non-Executive Director Independent Director Shamsudheen Bin Alisha Moopen Chenayappillil John George Deputy Managing Director Mohideen Mammu Haji Independent Director
Slide 41: www.asterdmhealthcare.com
www.asterdmhealthcare.com